AAM
NUVB icon

AMI Asset Management’s Nuvation Bio NUVB Stock Holding History

AMI Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
183,251
-9,176
-5% -$44.8K 0.06% 53
2026
Q1 		$826K Buy
192,427
+65,955
+52% +$367K 0.05% 64
2025
Q4 		$1.13M Buy
+126,472
New +$783K 0.06% 55

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

AMI Asset Management's NUVB Position: Q2 2026 in Review

AMI Asset Management reduced its Nuvation Bio (NUVB) stake by 4.8% in Q2 2026, selling an estimated $44.8K and leaving 183,251 shares worth $1.04M. The position accounts for 0.06% of the portfolio, ranked #53.

AMI Asset Management first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.13M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • AMI Asset Management held 183,251 shares of Nuvation Bio worth $1.04M as of Q2 2026.
  • AMI Asset Management sold 9,176 Nuvation Bio shares in Q2 2026, an estimated $44.8K.
  • Nuvation Bio made up 0.06% of AMI Asset Management's portfolio in Q2 2026, its #53 holding.
  • AMI Asset Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • AMI Asset Management's Nuvation Bio position peaked at $1.13M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on AMI Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.